Skip to main content
16/06/2014

VHIR signs a collaboration agreement with the association of patients with Dent's disease

2014_0137_2014_0137_IMATGE

16/06/2014

Asdent will direct donations through ‘Yo Investigo’ in order to fund research on this rare pathology

Vall d’Hebron Institute of Research (VHIR) has signed a collaboration agreement with the "http://www.asdent.es/index.php" association of patients with Dent’s disease, chaired by Eva Giménez, mother of a 4 year-old child with this rare disease of the kidney.The agreement will direct through the VHIR’s fundraising website "http://www.yoinvestigo.org/" 'Yo Investigo' all the donations addressed to research projects, studies and clinical trials at VHIR. Another goal is to spread the fundraising activities of the association and to improve the comprehension and knowledge of this disease.Dent’s disease is a rare X-linked recessive inherited condition that exclusively affects the kidney. It causes the loss of essential proteins for the organism and the expulsion through the urine of calcium, phosphorus, magnesium and glucose. There is not any treatment available to cure the disease and the future of these patients is uncertain. Nacho is a champion and his parents are true fighters. During Eva’s pregnancy, doctors from Vall d’Hebron found neurological problems in her fetus and she suffered several complications (iron deficiency, Toxoplasmosis infection and excessive amniotic fluid). Nacho was born in the week 35, with respiratory problems and a small hemorrhagic stroke. After several visits to the hospital, he was eventually diagnosed with Dent’s disease at the age of 18 months. Since then his parents have raised more than 100.000 euros organizing all kind of activities: collecting plastic bottle caps, organizing concerts, benefit events and even participating in the "http://www.sport.es/es/noticias/deporte-extremo/asdent-conquista-titan-desert-para-nacho-2381102" Titan Desert! Now with this agreement that they have signed together with Nacho’s doctor and head of the Nephrology Service, Dr. Gema Ariceta, they look forward to advance in the research of this disease that in Spain affects 38 people.

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.